Treatment of Hypertension in Urgent Care Setting
For hypertensive urgencies (BP >180/120 mmHg without end-organ damage), initiate oral antihypertensive therapy with a low dose of captopril 25 mg, while hypertensive emergencies require immediate hospitalization for parenteral antihypertensive administration. 1, 2
Distinguishing Hypertensive Urgency vs. Emergency
Hypertensive Urgency:
- Severe BP elevation (>180/120 mmHg)
- No evidence of acute end-organ damage
- Can be managed in outpatient setting
- Requires BP reduction within 24-48 hours
Hypertensive Emergency:
- Severe BP elevation (>180/120 mmHg)
- Evidence of new/worsening target organ damage
- Requires hospitalization and ICU admission
- Requires immediate parenteral antihypertensive therapy
- One-year mortality rate >79% if untreated 2
Evaluation in Urgent Care
- Assess for symptoms of target organ damage:
- Neurological: Headache, altered mental status, seizures, focal deficits
- Cardiac: Chest pain, dyspnea, palpitations
- Renal: Oliguria, hematuria
- Visual: Blurred vision, visual field defects
- Review medication history, particularly recent discontinuation of antihypertensives
- Check for potential drug interactions that may elevate BP
Management of Hypertensive Urgency
First-line Oral Medications:
ACE inhibitors (preferred):
Alternative options:
- ARBs: For patients with ACE inhibitor intolerance
- Beta-blockers: Metoprolol (use with caution in reactive airway disease)
- Calcium channel blockers: Avoid immediate-release nifedipine due to risk of precipitous BP drop 2
BP Reduction Goals:
- Reduce BP by no more than 25% within first hour
- Then to 160/100 mmHg over next 2-6 hours
- Gradually normalize over 24-48 hours 1, 2
Monitoring:
- Monitor vital signs every 30 minutes for first 2 hours
- Observe for at least several hours to ensure stability before discharge
- Schedule follow-up within 24 hours 2
Management of Hypertensive Emergency
Immediate Actions:
- Transfer to emergency department/ICU
- Continuous BP monitoring (preferably intra-arterial)
- Initiate parenteral antihypertensive therapy 1
First-line IV Medications:
Labetalol: Initial dose 0.3-1.0 mg/kg (max 20 mg) IV every 10 minutes, followed by infusion at 0.4-1.0 mg/kg/h 2
Nicardipine: Initial 5 mg/h, increasing by 2.5 mg/h every 5 minutes to maximum 15 mg/h 1, 2
Clevidipine: Initial 1-2 mg/h, doubling every 90 seconds until BP approaches target, maximum 32 mg/h 1, 2
Specific Clinical Scenarios:
- Aortic dissection: Esmolol + nitroprusside; reduce SBP to <120 mmHg within first hour 1, 2
- Acute coronary event: Nitroglycerin preferred 2
- Acute pulmonary edema: Nitroglycerin + loop diuretic 2
- Preeclampsia/eclampsia: Reduce SBP to <140 mmHg within first hour; hydralazine often used 1, 2
Common Pitfalls to Avoid
Overly aggressive BP reduction - Can cause cerebral hypoperfusion, acute kidney injury, and worsening of neurological status
Using immediate-release nifedipine - Associated with unpredictable BP drops and adverse outcomes
Prolonged use of sodium nitroprusside - Risk of cyanide toxicity; should be used for shortest possible duration
Discharging patients too quickly - Patients require observation and close follow-up to prevent progression to hypertensive emergency
Using beta-blockers in suspected catecholamine excess - Contraindicated in pheochromocytoma or cocaine toxicity without alpha-blockade
Failing to address underlying causes - Medication non-adherence, substance abuse, and secondary causes should be identified and addressed
Remember that untreated hypertensive emergencies have a >79% one-year mortality rate, emphasizing the need for prompt recognition and appropriate management 2.